These results, along with a past report exhibiting that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like actions in mice,two help the thought of targeting ACKR3 as a unique technique to modulate the opioid technique, which could open new therapeutic avenues for opioid-connected Issues.In reaction to this issue, the new review appeared